We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Image of Alison Halliday, PhD

Alison Halliday, PhD


Dr. Alison Halliday is an award-winning freelance science communications specialist with 20+ years of experience across academia, industry and the third sector – including ten years at the world’s largest cancer charity. She is skilled at translating complex information into jargon-free, engaging, stories – specializing in topics across the life sciences, medicine and health. After completing her PhD in molecular genetics at the University of Newcastle, she carried out five years of postdoctoral research at University College London before moving into science communications. She now works with a variety of clients to bring their research to life – including companies that need support with their product marketing, or organizations looking to engage with their audiences about the latest advances in biomedicine.


Got a question for Alison Halliday, PhD?


Get in touch using the contact form linked here and we’ll get back to you shortly



Published Content
Total: 42
High-Throughput Screening: Using a More Intelligent Approach for Hit Discovery content piece image
Article

High-Throughput Screening: Using a More Intelligent Approach for Hit Discovery

While industrial laboratories can screen vast numbers of potential drug compounds, many academic researchers are adopting more focused strategies.
The Role of the Host Immune Response in COVID-19: Friend or Foe? content piece image
Article

The Role of the Host Immune Response in COVID-19: Friend or Foe?

One of the biggest mysteries of the current pandemic is why outcomes from SARS-CoV-2 infection vary so widely between different people. Researchers are searching for clues in the host immune response to the virus.
Advances in Medicinal Chemistry content piece image
Article

Advances in Medicinal Chemistry

Medicinal chemists play a crucial role in drug discovery through the selection, synthesis and testing of a myriad of compounds. Recent advances in technologies are set to accelerate their progress.
The Importance of Diagnostics in Tackling the COVID-19 Pandemic content piece image
Article

The Importance of Diagnostics in Tackling the COVID-19 Pandemic

Large-scale testing and contact tracing are central to efforts to control the pandemic. This relies on diagnostic tests that can rapidly, accurately and reliably detect SARS-CoV-2.
Sequencing the Human Microbiome: Opening the Black Box content piece image
Article

Sequencing the Human Microbiome: Opening the Black Box

Researchers are using sequencing technologies to rapidly expand our knowledge of the human microbiome and identify undiscovered bacterial genomes.
The Therapeutic Antibody Revolution content piece image
Article

The Therapeutic Antibody Revolution

A crucial component of our immune system, antibodies are now the most rapidly growing class of approved biopharmaceutical drugs. We explore the past, present and future of therapeutic monoclonal antibodies.
Cancer Biomarkers: Powering Precision Medicine content piece image
Article

Cancer Biomarkers: Powering Precision Medicine

Researchers are developing biomarker tests to detect cancer early, monitor therapeutic efficacy and predict outcomes – making diagnosis and treatment more precise.
Lipidomics – A Niche but Rapidly Growing Field content piece image
Article

Lipidomics – A Niche but Rapidly Growing Field

Although researchers have been working on lipid biochemistry for many decades, lipidomics is a more recent, newly emerging discipline – with potential applications for diagnosing and preventing disease.

Uncovering the Secrets of the Breast Cancer Epigenome content piece image
Article

Uncovering the Secrets of the Breast Cancer Epigenome

The epigenome plays a crucial role in the development of breast cancer. This exciting and rapidly evolving area of research holds great promise for new interventions – from prevention through to personalized treatment.
Targeting TGF-β Signaling in Cancer: A Double-edged Sword content piece image
Article

Targeting TGF-β Signaling in Cancer: A Double-edged Sword

Transforming growth factor (TGF)-β signaling is an attractive therapeutic target as it is deregulated in many cancers. But challenges remain around developing inhibitors that can specifically block tumor-promoting activities while preserving its tumor suppressive effects.
Advertisement